During the corresponding time, Avanos Medical Inc recorded a revenue increase by 9.23 % year on year, sequentially revenue grew by 0.72 %. While revenue at the Avanos Medical Inc 's corporate clients
Avanos Medical Inc's Comment on Sales, Marketing and Customers
In the year ended December 31, 2025, approximately 49% of the company's net sales in North America were made through distributors. Sales to Medline Industries represented about 12% of consolidated net sales in 2025. In 2024, sales to McKesson Corporation and Medline Industries accounted for approximately 18% and 17% of consolidated net sales, respectively. In 2023, sales to Medline Industries, McKesson Corporation, and Owens & Minor, Inc. represented approximately 15%, 13%, and 6% of consolidated net sales, respectively. Outside North America, about 67% of net sales were made through wholesalers or distributors in 2025. The company operates distribution centers in North America, Europe, Australia, and Japan. Approximately 29% of global net sales in 2025 were contracted through Group Purchasing Organizations (GPOs), which negotiate pricing and volume discounts for hospitals, physician practices, and other healthcare providers and institutions. Major competitors include Boston Scientific Corporation, Cook Medical, Applied Medical Technology, Inc., Cardinal Health, Pacira Pharmaceuticals, Inc., Stryker Corporation, Medtronic plc, Pajunk Medical Systems, Stratus Medical, and Nice Recovery Systems. In 2025, the company expanded its portfolio into the vascular access market through the Nexus Acquisition, enhancing its product offerings and relevance with current customers.
Avanos Medical Inc’s Comment on Sales, Marketing and Customers
In the year ended December 31, 2025, approximately 49% of the company's net sales in North America were made through distributors. Sales to Medline Industries represented about 12% of consolidated net sales in 2025. In 2024, sales to McKesson Corporation and Medline Industries accounted for approximately 18% and 17% of consolidated net sales, respectively. In 2023, sales to Medline Industries, McKesson Corporation, and Owens & Minor, Inc. represented approximately 15%, 13%, and 6% of consolidated net sales, respectively. Outside North America, about 67% of net sales were made through wholesalers or distributors in 2025. The company operates distribution centers in North America, Europe, Australia, and Japan. Approximately 29% of global net sales in 2025 were contracted through Group Purchasing Organizations (GPOs), which negotiate pricing and volume discounts for hospitals, physician practices, and other healthcare providers and institutions. Major competitors include Boston Scientific Corporation, Cook Medical, Applied Medical Technology, Inc., Cardinal Health, Pacira Pharmaceuticals, Inc., Stryker Corporation, Medtronic plc, Pajunk Medical Systems, Stratus Medical, and Nice Recovery Systems. In 2025, the company expanded its portfolio into the vascular access market through the Nexus Acquisition, enhancing its product offerings and relevance with current customers.
Sources:
Avanos Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Avanos Medical Inc’s corporate clients.
For your research, we’ve provided 9 tables on Avanos Medical Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
68.06 %